In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
How Type 2 Diabetes (T2D) remission sounds impossible, but is achievable and endorsed by Diabetes Australia in their "Type 2 Diabetes Position Statement" October 2021, and The compelling and beneficial impact of introducing a low carb dietary intervention to patients with T2D, rather than surgery or prescribing more drugs.
Patients on medications that have a low incidence of hypoglycaemia with T2DM do not need finger-prick blood glucose testing. GPs will rely on HbA1C to guide management. However, its use in Sick Days management is still important
Decisions regarding glycaemic control may not be simple as there are situations where you strive for tighter control or settle for less than satisfactory control